Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waidon (Beijing) Biotechnology is a high-tech enterprise specializing in the research, development, production, and sales of in vitro diagnostic (IVD) reagents and instruments. The company focuses on providing comprehensive solutions for molecular diagnostics and point-of-care testing (POCT) across various clinical applications, including infectious disease screening and chronic disease management. Waidon leverages advanced biotechnology to develop high-sensitivity detection kits and automated diagnostic platforms designed for clinical laboratories and bedside testing. Their product portfolio includes a range of rapid diagnostic tests and supporting equipment aimed at improving the efficiency and accuracy of medical diagnosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waidon.